ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $73,000 | +102.8% | 42,441 | +196.5% | 0.00% | – |
Q4 2020 | $36,000 | -77.9% | 14,313 | -77.9% | 0.00% | -100.0% |
Q3 2020 | $163,000 | -73.5% | 64,621 | -65.7% | 0.00% | -62.5% |
Q2 2020 | $616,000 | +962.1% | 188,188 | +1620.0% | 0.01% | 0.0% |
Q4 2016 | $58,000 | – | 10,941 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
G&S Capital LLC | 18,000 | $34,000 | 0.03% |